Outlook Therapeutics (OTLK) EBT Margin (QoQ) (2015 - 2025)
Outlook Therapeutics (OTLK) EBT Margin (QoQ) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Outlook Therapeutics |
51.56 Mn |
43.81 Mn |
-21,888.00 |
| Date | Value |
|---|
| Sep 30, 2025 |
1.75 Mn |
| Sep 30, 2019 |
67,632.00 |
| Jun 30, 2019 |
70,411.00 |
| Mar 31, 2019 |
-68,540.00 |
| Dec 31, 2018 |
73,244.00 |
| Sep 30, 2018 |
-55,257.00 |
| Jun 30, 2018 |
-11,557.00 |
| Mar 31, 2018 |
-31,982.00 |
| Dec 31, 2017 |
-45,452.00 |
| Sep 30, 2017 |
155,625.00 |
| Jun 30, 2017 |
89,550.00 |
| Mar 31, 2017 |
364,468.00 |
| Dec 31, 2016 |
-416,350.00 |
| Sep 30, 2016 |
237,606.00 |
| Jun 30, 2016 |
-416,048.00 |
| Mar 31, 2016 |
133,887.00 |
| Dec 31, 2015 |
195,758.00 |
| Sep 30, 2015 |
-275,156.00 |
| Jun 30, 2015 |
207,600.00 |
